Cognitive Performance and Plasma Levels of Homocysteine, Vitamin B12, Folate and Lipids in Patients with Alzheimer Disease
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
Background: Conflicting results have been reported on the association of plasma total homocysteine (tHcy) and cholesterol levels in Alzheimer disease (AD). The objective of this study was to determine the relationship between cognitive performance and plasma levels of tHcy and its biological determinants folate and vitamin B 12, and lipids in clinically diagnosed AD patients. Methods: A cross-sectional database review was performed on two separate groups of patients (n = 191). Mini-Mental State Exam (MMSE) scores, plasma levels of tHcy, vitamin B 12, folate, cholesterol, and triglycerides were analyzed. Results: The MMSE scores were inversely correlated with age, plasma levels of tHcy and LDL cholesterol. However, only the inverse relationship between MMSE scores and LDL cholesterol levels persisted after adjustment for age, sex, and status of statin treatment. Plasma tHcy levels increased significantly with age and were inversely related to vitamin B 12 and folate levels, which modified the relationship between MMSE scores and plasma tHcy levels. Conclusions: The plasma tHcy levels appeared to relate more to aging than to cognition. Cognitive performance was inversely associated with plasma LDL cholesterol levels in AD patients. Our findings provide further evidence that high LDL cholesterol levels may play a role in the pathogenesis of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An antagonistic interaction of folate and Vitamin B-12 with Hcy’s effect on cognition was noted in other studies [224,296,297].”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [296]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · cited 1×
“Patients with MCI were excluded from this analysis. Only patients with a diagnosis of probable or possible AD according to NINCDS-ADRDA criteria [”
MethodHirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“All of these mutations cause increased production of highly amyloidogenic Aβ peptides that are deposited in the senile plaques.Increasing evidence suggests that cardiovascular risk factors may play important roles in the development of AD. The apolipoprotein (apo) E4 allele, associated with hypercholesterolemia and co…”
BackgroundMild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378 · cited 1×
“Prospective studies, however, have produced mixed results on the effect of statins on the development of AD [ , ,”
ResultPlasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 1×
“has also been implicated as a strong and independent risk factor for the development of dementia and AD [”
BackgroundHyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161 · cited 1×
“Another risk factor for vascular disease, elevated plasma total homocysteine (tHcy) levels [”
BackgroundVitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972 · cited 1×
“Plasma tHcy levels are influenced by vitamin B12 and folate intake. Vitamin B 12 and folate are needed for the conversion of homocysteine to methionine [”
BackgroundStatins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408 · cited 1×
“Two case-control studies showed higher plasma tHcy levels in people with AD [ ,”
BackgroundWolozin, B. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,398 · cited 1×
“Recent epidemiological data have indicated an apparent reduction of AD prevalence in people treated with statins, a class of cholesterol-lowering drugs [”
BackgroundAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · cited 1×
“This hypothesis is supported by discoveries of causative mutations in the gene encoding amyloid-β precursor protein (APP) and in genes of presenilin-1 and -2 in early-onset familial AD [”
BackgroundThe prevalence of dementia: A quantitative integration of the literature
Jorm, A. F., Korten, A. E., & Henderson, A. S. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02906.x · Cited by 1,296
Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,166 · cited 1×
“When cellular cholesterol levels are reduced with a cholesterol-lowering drug, the production of Aβ is inhibited due to changes in enzyme activities that are involved in the proteolytic processing of APP [”
BackgroundFassbender, K., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 860 · cited 1×
“When cellular cholesterol levels are reduced with a cholesterol-lowering drug, the production of As is inhibited due to changes in enzyme activities that are involved in the proteolytic processing of APP [ , ,”
BackgroundLow cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10
Kojro, E., Gimpl, G., Lammich, S., März, W., & Fahrenholz, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081612998 · Cited by 804
Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model
Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 783 · cited 1×
“and accelerates cerebral Aβ deposition in APP transgenic mice [”
BackgroundSerum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease
Notkola, I.-L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 669
Riggs, K., Spiro, A., Tucker, K., & Rush, D. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.3.306 · Cited by 509
Sparks, D. L., Scheff, S. W., Hunsaker, J. C., Liu, H., Landers, T., & Gross, D. R. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1044 · Cited by 443
Simons, M., Schwärzler, F., Lütjohann, D., Von Bergmann, K., Beyreuther, K., Dichgans, J., Wormstall, H., Hartmann, T., & Schulz, J. B. (2002) · Annals of Neurology · doi:10.1002/ana.10292 · Cited by 415 · cited 1×
“Prospective studies, however, have produced mixed results on the effect of statins on the development of AD [”
ResultTotal serum homocysteine in senile dementia of Alzheimer type
McCaddon, A., Davies, G., Hudson, P., Tandy, S., & Cattell, H. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199804)13:4<235::aid-gps761>3.0.co;2-8 · Cited by 398 · cited 1×
“Two case-control studies showed higher plasma tHcy levels in people with AD [”
BackgroundCholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein
Bodovitz, S., & Klein, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4436 · Cited by 359
The role of cholesterol in the biosynthesis of β-amyloid.
Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H., & Austen, B. M. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00014 · Cited by 324
Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease: Preliminary Results
Sparks, D. L., Sabbagh, M. N., Connor, D. J., Lopez, J., Launer, L. J., Browne, P., Wasser, D., Johnson-Traver, S., Lochhead, J., & Ziolwolski, C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.753 · Cited by 319 · cited 1×
“Prospective studies, however, have produced mixed results on the effect of statins on the development of AD [ ,”
ResultPlasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease: The Framingham Study
Tan, Z. S., Seshadri, S., Beiser, A., Wilson, P. W. F., Kiel, D. P., Tocco, M., D'Agostino, R. B., & Wolf, P. A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1053 · Cited by 280 · cited 1×
“Furthermore, several observational epidemiological studies examining the association between plasma cholesterol levels and AD have yielded conflicting results [”
ResultMerched, A., Xia, Y., Visvikis, S., Serot, J. M., & Siest, G. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00103-7 · Cited by 272 · cited 1×
“Levels of atheroprotective plasma lipoprotein components, HDL cholesterol and apoA-I, are decreased in AD patients [”
BackgroundCortical senile plaques in coronary artery disease, aging and Alzheimer's disease
Sparks, D. L., Hunsaker, J. C., Scheff, S. W., Kryscio, R. J., Henson, J. L., & Markesbery, W. R. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90024-t · Cited by 271 · cited 1×
“increasing lines of evidence have suggested that cholesterol metabolism plays an important role in the pathogenesis of AD. Epidemiologically, an increase in prevalence of cerebral senile plaques is found in cognitively intact individuals with heart disease compared to age-matched controls with no heart disease [”
BackgroundHaan, M. N., Miller, J. W., Aiello, A. E., Whitmer, R. A., Jagust, W. J., Mungas, D. M., Allen, L. H., & Green, R. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.511 · Cited by 260
Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker
Lehmann, M., Gottfries, C. G., & Regland, B. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017092 · Cited by 245 · cited 1×
“Plasma levels of vitamin B 12 and folate were not related to cognitive performance but were inversely related to plasma tHcy levels.Elevated plasma tHcy levels, a risk factor for cardiovascular disease, have been shown to be associated with an increased risk for dementia and AD. Several reports indicated an inverse as…”
BackgroundElevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 Levels
Kuo, Y.-M., Emmerling, M. R., Bisgaier, C. L., Essenburg, A. D., Lampert, H. C., Drumm, D., & Roher, A. E. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9652 · Cited by 238 · cited 1×
“Levels of atherogenic plasma lipoprotein components, LDL cholesterol and apoB, are increased in AD patients and correlate with brain Aβ levels [”
BackgroundKalmijn, S., Launer, L. J., Lindemans, J., Bots, M. L., Hofman, A., & Breteler, M. M. B. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010000 · Cited by 237
Evans, R. M., Emsley, C. L., Gao, S., Sahota, A., Hall, K. S., Farlow, M. R., & Hendrie, H. (2000) · Neurology · doi:10.1212/wnl.54.1.240 · Cited by 209
Association between Statin Use and Alzheimer’s Disease
Zamrini, E., McGwin, G., & Roseman, J. M. (2004) · Neuroepidemiology · doi:10.1159/000073981 · Cited by 202 · cited 1×
“Recent epidemiological data have indicated an apparent reduction of AD prevalence in people treated with statins, a class of cholesterol-lowering drugs [ , ,”
BackgroundSelf-citationMorris, M. S., Jacques, P. F., Rosenberg, I. H., & Selhub, J. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.5.927 · Cited by 186
Diet-induced hypercholesterolemia enhances brain Aβ accumulation in transgenic mice
Shie, F.-S., Jin, L.-W., Cook, D. G., Leverenz, J. B., & LeBoeuf, R. C. (2002) · Neuroreport · doi:10.1097/00001756-200203250-00019 · Cited by 184
Plasma homocysteine levels and risk of Alzheimer disease
Luchsinger, J. A., Tang, M. X., Shea, S., Miller, J., Green, R., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000129504.60409.88 · Cited by 171
APOE genotype, plasma lipids, lipoproteins, and AD in community elderly
Romas, S. N., Tang, M.-X., Berglund, L., & Mayeux, R. (1999) · Neurology · doi:10.1212/wnl.53.3.517 · Cited by 169
THE GENETICS AND MOLECULAR PATHOLOGY OF ALZHEIMER'S DISEASE
Selkoe, D. J. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70232-2 · Cited by 162
Plasma Homocysteine Levels and Risk of Alzheimer Disease
Bissell, M. G. (2006) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/s1077-9108(08)70193-2 · Cited by 151
Simvastatin enhances learning and memory independent of amyloid load in mice
Li, L., Cao, D., Kim, H., Lester, R., & Fukuchi, K. (2006) · Annals of Neurology · doi:10.1002/ana.21053 · Cited by 150 · cited 1×
“Recently, we have demonstrated that a statin drug enhances learning and memory in normal aged mice as well as in mice with AD-like pathology [”
BackgroundSelf-citationHomocysteine and cognitive function in the Sacramento Area Latino Study on Aging
Miller, J. W., Green, R., Ramos, M. I., Allen, L. H., Mungas, D. M., Jagust, W. J., & Haan, M. N. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.441 · Cited by 134
Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people
Bell, I. R., Edman, J. S., Selhub, J., Morrow, F. D., Marby, D. W., Kayne, H. L., & Cole, J. O. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03285.x · Cited by 131 · cited 1×
“Plasma levels of vitamin B 12 and folate were not related to cognitive performance but were inversely related to plasma tHcy levels.Elevated plasma tHcy levels, a risk factor for cardiovascular disease, have been shown to be associated with an increased risk for dementia and AD. Several reports indicated an inverse as…”
BackgroundLevin-Allerhand, J. A., Lominska, C. E., & Smith, J. D. (2002) · PubMed · Cited by 117
Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice
Cao, D., Fukuchi, K.-I., Wan, H., Kim, H., & Li, L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.011 · Cited by 106 · cited 1×
“In addition, we have shown that lack of the LDL receptor, which causes hypercholesterolemia, aggravates cerebral β-amyloidosis and learning deficits in a mouse model of AD [”
BackgroundSelf-citationLi, L., Cao, D., Garber, D. W., Kim, H., & Fukuchi, K.-I. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63572-9 · Cited by 105
Self-citationEllinson, M., Thomas, J., & Patterson, A. (2004) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2004.00532.x · Cited by 92 · cited 1×
“] or cognitive function in either cross-sectional [ , ,”
BackgroundIncreased apolipoprotein B serum concentration in Alzheimer's disease
Caramelli, P., Nitrini, R., Maranhão, R., Lourenço, A. C. G., Damasceno, M. C., Vinagre, C., & Caramelli, B. (1999) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00724.x · Cited by 74 · cited 1×
“Levels of atherogenic plasma lipoprotein components, LDL cholesterol and apoB, are increased in AD patients and correlate with brain As levels [ ,”
BackgroundPlasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging.
Mizrahi, E. H., Jacobsen, D. W., Debanne, S. M., Traoré, F., Lerner, A. J., Friedland, R. P., & Petot, G. J. (2003) · PubMed · Cited by 63
Relation between Plasma Homocysteine and Alzheimer’s Disease
Nilsson, K., Gustafson, L., & Hultberg, B. L. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000058327 · Cited by 50 · cited 1×
“Other studies, however, found no association between plasma tHcy levels and AD [”
Ravaglia, G., Forti, P., Maioli, F., Zanardi, V., Dalmonte, E., Grossi, G., Cucinotta, D., Macini, P. L., & Caldarera, M. (2000) · PubMed · Cited by 48
Research works printed but not linked: 2
- 10.1001%2fjama.274.13.1049 · doi:10.1001/jama.274.13.1049 · Paper page
- 10.1001%2fjama.270.22.2693 · DOI
Cited by
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
“An antagonistic interaction of folate and Vitamin B-12 with Hcy’s effect on cognition was noted in other studies [224,296,297].”
ResultReitz, C., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.297 · Cited by 205
Wang, Z., Zhu, W., Xing, Y., Jia, J., & Tang, Y. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab057 · Cited by 144
Li, H., Kang, T., Qi, B., Kong, L., Jiao, Y., Cao, Y., Zhang, J., & Yang, J. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.020 · Cited by 129
Metadata
- Authors
- Li, L., Cao, D., Desmond, R., Rahman, A., Lah, J. J., Levey, A. I., & Zamrini, E.
- Affiliations
- University of Alabama at Birmingham (US)
- Emory University (US)
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 26
- Issue
- 4
- Pages
- 384-390
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- PMC
- PMC2679366
- OpenAlex
- W1998386491
- Cited by
- 45
- References
- 60
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 5 · 2012: 2
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health
- National Institute on Aging (AG 031846, R21AG025949, R01AG031846, AG 16582, P50AG016582, AG025949, P50AG025688)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, homocysteine, vitamin B12, folic acid, LDL cholesterol, triglycerides, cognitive performance, Mini-Mental State Examination, aging, statin therapy, lipid metabolism
- MeSH terms
- Aged, Alzheimer Disease, Cognition, Cross-Sectional Studies, Female, Folic Acid, Homocysteine, Humans, Lipids, Cholesterol, HDL, Cholesterol, LDL, Male, Psychomotor Performance, Sex Characteristics, Triglycerides, Vitamin B 12, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.